SCHEMBL6062848

SCHEMBL6062848

CC(C)CCN(C(=O)O)C(=O)N[C@@H](CCc1ccccc1)C(=O)c1nc(C(=O)N(C)C23CC4CC(CC(C4)C2)C3)co1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 5/20 0.39
TP53 P04637 2/20 0.34
USP2 O75604 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CTSL P07711 3/20 0.33
CTSB P07858 2/20 0.32
CTSS P25774 2/20 0.32
CTSK P43235 2/20 0.32
CES1 P23141 1/20 0.32
ALDH1A1 P00352 2/20 0.32
CNR2 P34972 1/20 0.31
EPHX2 P34913 2/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6461816 0.84 DAGLA (0.42) DAGLATP53USP2ALOX15TSHR
SCHEMBL7529171 0.80 DAGLA (0.40) DAGLATP53MAPK1CES1ALDH1A1
SCHEMBL7047182 0.77 DAGLA (0.39) DAGLATP53USP2ALOX15TSHR
SCHEMBL7529166 0.75 KMT2A (0.42) KMT2A
SCHEMBL6475526 0.72 FAAH (0.46) DAGLACTSLCTSBCTSSCTSK
SCHEMBL6461813 0.71 P2RX7 (0.40) DAGLACTSLEPHX2EPHX1
SCHEMBL6467558 0.67 FAAH (0.46) DAGLACTSLCTSBCTSSCTSK
SCHEMBL6063695 0.66 DAGLA (0.38) DAGLACTSLCTSBCTSSCTSK
SCHEMBL6063413 0.66 CTSL (0.50) CTSLCTSBCTSSCTSKALDH1A1
SCHEMBL7567535 0.65 DAGLA (0.43) DAGLACES1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed